Probiotec (ASX: PBP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Probiotec Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Probiotec (ASX: PBP)
Latest News
Healthcare Shares
2 ASX healthcare shares to buy that you've not heard of: expert
Healthcare Shares
Why the Probiotec (ASX:PBP) share price is surging 7% today
Share Gainers
Why the IDT Australia (ASX:IDT) share price is up 150% in just 2 days
Share Market News
Why the Probiotec (ASX:PBP) share price is trading higher
Share Gainers
Why this small cap ASX share zoomed 7% higher today
Share Gainers
These small cap ASX shares are pushing higher on Thursday
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 04 Jun 2024 | $0.0375 | 100.00% | Special Cash | 18 Jun 2024 |
| 04 Mar 2024 | $0.0350 | 100.00% | Interim | 15 Mar 2024 |
| 31 Aug 2023 | $0.0350 | 100.00% | Final | 08 Sep 2023 |
| 02 Mar 2023 | $0.0300 | 100.00% | Interim | 17 Mar 2023 |
| 07 Sep 2022 | $0.0350 | 100.00% | Final | 15 Sep 2022 |
| 03 Mar 2022 | $0.0200 | 100.00% | Interim | 18 Mar 2022 |
| 30 Sep 2021 | $0.0300 | 100.00% | Final | 08 Oct 2021 |
| 03 Mar 2021 | $0.0200 | 100.00% | Interim | 19 Mar 2021 |
| 22 Oct 2020 | $0.0300 | 100.00% | Final | 30 Oct 2020 |
| 03 Mar 2020 | $0.0150 | 100.00% | Interim | 19 Mar 2020 |
| 24 Oct 2019 | $0.0250 | 100.00% | Final | 31 Oct 2019 |
| 01 Mar 2019 | $0.0100 | 100.00% | Interim | 19 Mar 2019 |
| 07 Nov 2018 | $0.0500 | 100.00% | Special Cash | 15 Nov 2018 |
| 04 Sep 2018 | $0.0200 | 100.00% | Final | 04 Oct 2018 |
| 20 Mar 2018 | $0.0075 | 100.00% | Interim | 20 Apr 2018 |
| 04 Sep 2017 | $0.0000 | 100.00% | Final | 04 Oct 2017 |
| 21 Mar 2017 | $0.0050 | 100.00% | Interim | 21 Apr 2017 |
| 02 Sep 2016 | $0.0150 | 100.00% | Final | 04 Oct 2016 |
| 30 Aug 2010 | $0.0200 | 100.00% | Final | 01 Oct 2010 |
| 26 Feb 2010 | $0.0150 | 100.00% | Interim | 18 Mar 2010 |
| 28 Aug 2009 | $0.0200 | 100.00% | Final | 01 Oct 2009 |
| 05 Mar 2009 | $0.0125 | 100.00% | Interim | 27 Mar 2009 |
| 06 Mar 2008 | $0.0070 | 0.00% | Interim | 19 Mar 2008 |
PBP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Probiotec
Probiotec Ltd. engages in manufacture, market and distribution of over-the-counter pharmaceuticals, complementary medicines and specialty ingredients. It operates through the following segments: Branded Pharmaceuticals, Contract Manufacturing, Obesity and Weight Management, Europe, and Specialty Products. The Branded Pharmaceuticals segment involves the sale of branded pharmaceutical products. The Contract Manufacturing segment involves the contract manufacturing of pharmaceutical, food and animal nutrition products on behalf of domestic and international pharmaceutical and food companies. The Obesity and Weight Management segment is involved in the manufacture and sale of a range of products across a number of channels including FMCG, pharmacy, health food stores and online. The Europe segment is involved in the manufacture and sale of products within Europe. The Specialty Products segment involves in the sale of human and animal nutrition products, incorporating the sale of ingredients and additives for use in the pharmaceutical and food industries. The company was founded in 1997 and is headquartered in Melbourne, Australia.
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 12 Jan 2024 | Wesley Stringer | Sell | 3,007 | $8,630 |
On-market trade.
|
| 11 Jan 2024 | Wesley Stringer | Sell | 133,865 | $384,192 |
On-market trade.
|
| 10 Jan 2024 | Wesley Stringer | Sell | 121,993 | $351,339 |
On-market trade.
|
| 09 Jan 2024 | Wesley Stringer | Sell | 929 | $2,684 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Wesley Stringer | Managing DirectorChief Executive Officer | Apr 2010 |
Mr Wesley was previously employed by KPMG in Taxation and Finance. He has also worked internationally for Deutsche Bank and BNP Paribas Investment Bank in London. From 1 July 2015, Wesley has taken the role of Chief Executive Officer of Probiotec Limited.
|
| Mr Jared Stringer | Chief Financial OfficerCompany SecretaryNon executive director | Jun 2024 |
Mr Stringer began employment with Probiotec as a Financial Accountant in 2006 before being appointed as Chief Financial Officer in 2012. He is a member of the society of Certified Practicing Accountants of Australia and also holds a Graduate Diploma of Applied Corporate Governance.
|
| Mr Andrew Phillips | Non-Executive Director | Jun 2024 |
--
|
| Jessica Walters | Chief Customer Officer |
-
|
|
| Julie McIntosh | Chief Operating Officer |
-
|
|
| Annalinde Nickisch | Chief People Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Hsbc Custody Nominees (Australia) Limited | 15,778,502 | 19.40% |
| National Nominees Limited | 9,236,082 | 11.36% |
| Wesley Stringer | 4,860,000 | 5.98% |
| J P Morgan Nominees Australia Pty Limited | 4,715,541 | 5.80% |
| Inston Pty Ltd <Stringer Super Fund A/C> | 4,052,359 | 4.98% |
| Mr Jared Stringer | 3,160,000 | 3.89% |
| Bnp Paribas Noms Pty Ltd <Drp> | 2,828,920 | 3.48% |
| Citicorp Nominees Pty Limited | 2,446,220 | 3.01% |
| Mr Charles Wayne Stringer | 2,438,574 | 3.00% |
| Inston Pty Ltd <Stringer Family A/C> | 2,330,313 | 2.87% |
| Bond Street Custodians Limited <Salter D79836 A/C> | 1,997,990 | 2.46% |
| Ganter Corporation Pty Ltd <Ganter Family A/C> | 1,993,015 | 2.45% |
| Bath Road Pty Ltd <Bath Road A/C> | 1,801,881 | 2.22% |
| Julie Mcintosh | 1,490,000 | 1.83% |
| Mr Adam Joseph Aundre Rawson | 1,042,794 | 1.28% |
| Mt Smith Group Pty Ltd <Mt Smith Family A/C> | 703,000 | 0.86% |
| Mr Peter William Coghill & Mrs Debbie Anne Coghill <P & D Coghill S/Fund A/C> | 609,700 | 0.75% |
| Rathvale Pty Limited | 604,204 | 0.74% |
| Mecs Super Pty Ltd <Mecs Super Fund A/C> | 547,427 | 0.67% |
| Bnp Paribas Noms (Nz) Ltd <Drp> | 540,532 | 0.67% |
